Načítá se...
Antithyroid Drug Treatment in Graves’ Disease
Graves’ disease is associated with thyrotropin (TSH) receptor stimulating antibody, for which there is no therapeutic agent. This disease is currently treated through inhibition of thyroid hormone synthesis or destruction of the thyroid gland. Recurrence after antithyroid drug (ATD) treatment is com...
Uloženo v:
| Vydáno v: | Endocrinol Metab (Seoul) |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Korean Endocrine Society
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8258321/ https://ncbi.nlm.nih.gov/pubmed/34130446 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3803/EnM.2021.1070 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|